biotimes

Amicogen succeeds in developing a ligand for next-generation antibody purification

2023-10-19 02:19:12 50-100% increase in antibody binding capacity, pH 4.0 elution efficiency, and NaOH stability compared to first-generation ligands. Widening the technology gap to accelerate entry into the global antibody purification resin market [바이오타임즈] Amicogen (CEO Park Cheol), which is leading the local production of essential biopharmaceutical component materials, announced on the 19th that it … Read more

Immunotherapy for Allergic Rhinitis – Visit Director Kim Hye-soo for Effective Treatment

2023-10-12 05:21:42 Help = Director Kim Hye-soo of Anyang Samsung Suo Otolaryngology Clinic [바이오타임즈] In the fall season like these, many people suffer from clear runny nose, sneezing, and stuffy nose as the nose’s ability to control the temperature and humidity of the air is weakened. These uncomfortable symptoms are one of the representative symptoms … Read more

Yuhan Corporation and Cyrus Therapeutics Collaborate to Develop Small Molecule Anticancer Targeted Therapies

2023-09-06 02:19:45 Expect synergy between Cyrus’ anti-cancer drug discovery capabilities and Yuhan’s translational clinical research capabilities Looking forward to quickly discovering the second Lexraza with global competitiveness From left, Kim Byung-moon, CEO of Cyrus Therapeutics, and Cho Wook-je, CEO of Yuhan Corporation (Photo Credit=Yuhan Corporation) [바이오타임즈] Yuhan Corp. (CEO Wook-Je Cho) announced that it had … Read more

New Discoveries in Controlling House Dust Mite-Induced Atopic Dermatitis: Research, Immune Factors, and Drug Candidates

2023-08-30 03:37:20 Research by specifying the house dust mite antigen, which accounts for about 70% of the prevalence of atopy The IP-10 factor secreted by house dust mites activates the infiltrated lymphocytes in the affected area to aggravate the condition. Discovery of new immune factors that can effectively control inflammation caused by house dust mites … Read more

Curacle applies for IND for high-dose phase 1b clinical trials, including ulcerative colitis treatment and immuno-anticancer drug combination therapy

2023-08-29 04:11:53 Flexibility in follow-up clinical dose selection ↑ Maximizes the safety window Possible positioning as a safer drug by widening the maximum margin of safety for candidates in the clinical trial stage [바이오타임즈] Curacle (365270, CEO Jae-Hyeon Yoo), a company specializing in the development of new drugs for incurable vascular diseases, has developed a … Read more

Frozen Shoulder: Causes, Symptoms, and Effective Treatment Methods

2023-08-16 03:28:57 Help = Park Yoon-hong, director of Wirye branch of Goodborn Rehabilitation Medicine Clinic [바이오타임즈] The exact disease name of frozen shoulder is adhesive capsulitis, and since it usually occurs in people in their 50s, the disease has been attached to the disease. However, if degenerative changes or other damage to the tissues around … Read more

Treating Rheumatoid Arthritis: Expert Advice from Dr. Won Je-beom, Asan Bon Internal Medicine

2023-08-05 01:00:00 Help = Dr. Won Je-beom, Asan Bon Internal Medicine [바이오타임즈] Rheumatoid arthritis is a chronic disease caused by one’s own immune system attacking the joints. It can appear anywhere on the body, and it constantly bothers the parts where the joints are located, especially the fingers and knees. Although the exact cause of … Read more

Facial Paralysis: Symptoms, Causes, and Treatment – Gwangmyeong Neurology Hospital Director’s Advice

2023-06-12 06:51:04 “It is important to actively start treatment by visiting a neurologist rather than recovering naturally” Shin Jong-hwa, director of Gwangmyeong 21st Century Hospital (Photo=Gwangmyeong 21st Century Hospital) [바이오타임즈] Sudden facial paralysis is a symptom caused by sudden paralysis of the facial nerve that controls the muscles of the face. In general, it plays … Read more